$51.52
Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing
Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?
Overview
52-week range
$25
$54
93% of range
Avg surprise (last 3)
+76.9%
Avg reaction (last 2)
+2.5%
100% positive
Latest IV / EM
55%
EM ±8.5% · $50 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.18 | — | — | — | — | financials |
| Tue May 5, 2026 | Mar/2026 | — | $-0.07 | +100.0% | +100.0% | +2.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.01 | — | — | — | — | financials |
| Tue Jul 29, 2025 | Jun/2025 | $-0.02 | $-0.15 | +86.7% | — | — | earnings |
| Tue Apr 29, 2025 | Mar/2025 | $-0.14 | $-0.25 | +44.0% | — | +2.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.17 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.17 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.28 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.20 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.11 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.14 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $154M | $141M | — | $134M | $136M | $124M | — | $116M |
| Cost of revenue | $35M | $32M | — | $33M | $35M | $31M | — | $29M |
| Gross profit | $119M | $109M | — | $101M | $101M | $93M | — | $87M |
| Operating income | $10M | $526,000 | — | $208,000 | $-6M | $-6M | — | $-7M |
| Net income | $9M | $108,000 | — | $-267,000 | $-6M | $-7M | — | $-8M |
| EPS (diluted) | $0.18 | — | — | $-0.01 | $-0.13 | $-0.14 | — | $-0.17 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $168M | $146M | $167M | $148M | $118M | $100M | $123M | $130M |
| Inventory | $84M | $81M | $78M | $79M | $76M | $75M | $75M | $77M |
| Total current assets | $346M | $314M | $323M | $301M | $271M | $251M | $268M | $269M |
| Total assets | $677M | $644M | $654M | $635M | $609M | $592M | $609M | $615M |
| Long-term debt | $61M | $61M | $62M | $62M | $62M | $62M | $62M | $62M |
| Total liabilities | $160M | $152M | $162M | $159M | $144M | $137M | $148M | $150M |
| Total equity | $516M | $492M | $492M | $477M | $464M | $455M | $461M | $465M |